Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Filella

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Advances in Laboratory Medicine|June 26, 2023
Towards personalized prostate cancer screeningXavier Filella
Advances in Laboratory Medicine|May 15, 2026
The evolving role of PSA in prostate cancer screening: revisiting the evidence in the era of personalized medicineXavier Filella
Clinical Chemistry and Laboratory Medicine|November 17, 2012
Evaluation of [-2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysisXavier Filella, Nuria Giménez
Advances in Laboratory Medicine|April 18, 2024
Xavier Filella, Núria Guañabens
European Urology|September 24, 2009
Re: Alberto Briganti, Michael L. Blute, James H. Eastham, et al. Pelvic lymph node dissection in prostate cancer. Eur urol 2009;55:1251-65Juan Alcover, Xavier Filella
Clinical Chemistry and Laboratory Medicine|January 12, 2016
miRNAs as novel biomarkers in the management of prostate cancerXavier Filella, Laura Foj
Advances in Experimental Medicine and Biology|September 20, 2018
Novel Biomarkers for Prostate Cancer Detection and PrognosisXavier Filella, Laura Foj
Clinical Chemistry and Laboratory Medicine|January 13, 2015
Emerging biomarkers in the detection and prognosis of prostate cancerXavier Filella, Laura Foj
International Journal of Molecular Sciences|October 30, 2016
Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal BiomarkersXavier Filella, Laura Foj
Clinical Genitourinary Cancer|July 22, 2015
Identification of Candidates for Active Surveillance: Should We Change the Current Paradigm?Joan Alcover, Xavier Filella
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Advances in Laboratory Medicine|June 26, 2023
Towards personalized prostate cancer screeningXavier Filella
Advances in Laboratory Medicine|May 15, 2026
The evolving role of PSA in prostate cancer screening: revisiting the evidence in the era of personalized medicineXavier Filella
Clinical Chemistry and Laboratory Medicine|November 17, 2012
Evaluation of [-2] proPSA and Prostate Health Index (phi) for the detection of prostate cancer: a systematic review and meta-analysisXavier Filella, Nuria Giménez
Advances in Laboratory Medicine|April 18, 2024
Xavier Filella, Núria Guañabens
European Urology|September 24, 2009
Re: Alberto Briganti, Michael L. Blute, James H. Eastham, et al. Pelvic lymph node dissection in prostate cancer. Eur urol 2009;55:1251-65Juan Alcover, Xavier Filella
Clinical Chemistry and Laboratory Medicine|January 12, 2016
miRNAs as novel biomarkers in the management of prostate cancerXavier Filella, Laura Foj
Advances in Experimental Medicine and Biology|September 20, 2018
Novel Biomarkers for Prostate Cancer Detection and PrognosisXavier Filella, Laura Foj
Clinical Chemistry and Laboratory Medicine|January 13, 2015
Emerging biomarkers in the detection and prognosis of prostate cancerXavier Filella, Laura Foj
International Journal of Molecular Sciences|October 30, 2016
Prostate Cancer Detection and Prognosis: From Prostate Specific Antigen (PSA) to Exosomal BiomarkersXavier Filella, Laura Foj
Clinical Genitourinary Cancer|July 22, 2015
Identification of Candidates for Active Surveillance: Should We Change the Current Paradigm?Joan Alcover, Xavier Filella
Pageof 13